Cargando…
In Vivo Trafficking of the Anticancer Drug Tris(8-Quinolinolato) Gallium (III) (KP46) by Gallium-68/67 PET/SPECT Imaging
KP46 (tris(hydroxyquinolinato)gallium(III)) is an experimental, orally administered anticancer drug. Its absorption, delivery to tumours, and mode of action are poorly understood. We aimed to gain insight into these issues using gallium-67 and gallium-68 as radiotracers with SPECT and PET imaging in...
Autores principales: | Darwesh, Afnan M. F., Imberti, Cinzia, Bartnicka, Joanna J., Al-Salemee, Fahad, Blower, Julia E., Rigby, Alex, Bordoloi, Jayanta, Griffiths, Alex, Ma, Michelle T., Blower, Philip J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609081/ https://www.ncbi.nlm.nih.gov/pubmed/37894695 http://dx.doi.org/10.3390/molecules28207217 |
Ejemplares similares
-
Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a (68)Ga-THP-scFv targeting the prostate-specific membrane antigen
por: Nawaz, Saima, et al.
Publicado: (2017) -
8-Quinolinolato Gallium Complexes: Iso-selective
Initiators for rac-Lactide Polymerization
por: Bakewell, Clare, et al.
Publicado: (2013) -
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
por: Cusnir, Ruslan, et al.
Publicado: (2017) -
Non-invasive radionuclide imaging of trace metal trafficking in health and disease: “PET metallomics”
por: Firth, George, et al.
Publicado: (2022) -
Re-assessing gallium-67 as a therapeutic radionuclide()
por: Othman, Muhamad F. bin, et al.
Publicado: (2017)